How to Build a Resilient Active Pharmaceutical Ingredient Production Process - Artificial Intelligence in API Manufacturing

How to Build a Resilient Active Pharmaceutical Ingredient Production Process - Artificial Intelligence in API Manufacturing

Dorota Owczarek - February 5, 2022 - updated on May 27, 2024

The active pharmaceutical ingredient (API) production process is a complex and delicate one. Any disruption can lead to a loss in revenue, and even product recalls. This is why it’s essential for manufacturers to build a resilient API production process that can withstand disruptions. The process must be handled carefully to maintain the quality and safety of the API products. This blog post will discuss how artificial intelligence can be used in API manufacturing to improve production efficiency and quality.

How Are APIs Manufactured?

The manufacturing of APIs can be divided into two main categories: synthetic and biologic, depending on the final compound produced:

  • chemical synthesis of APIs
  • biological processes (for fermentation-derived and cell line-based APIs)

The two processes are entirely different, segmenting the market of API production into synthetic chemical API and biological API.

In the case of synthetic APIs, a chemical reaction is used to produce the active ingredient. The most common method for producing synthetic APIs is through a process called crystallization. In this process, a dissolved active pharmaceutical ingredient is purified by being precipitated out of the solution as a solid crystal.

Biologic APIs are produced using biological processes such as fermentation or cell culture. These methods involve using microorganisms or cells to create the active ingredients. Biologic APIs tend to be more expensive and complex than synthetic ones.

How and Why API Manufacturers Are Applying Artificial Intelligence?

There are several reasons why API manufacturers are applying artificial intelligence to their production processes. Some of the key benefits of using AI in API manufacturing include:

  • Improved efficiency and quality
  • Increased throughput
  • Reduced costs
  • Improved product stability

Let’s take a closer look at each of these benefits in more detail.

Improved Efficiency and Quality

Using artificial intelligence in API manufacturing can improve the process’s efficiency and quality. With machine learning, it is possible to predict problems before they occur, which can help to prevent disruptions from happening. In addition, AI can be used for data analysis to identify trends and patterns that may not be visible to the human eye or apply more straightforward analytical methods. This can help to improve product quality by detecting problems with product purity, stability, and other chemical parameters.

Increased Throughput

Throughput is the amount of product produced in a given time. By using artificial intelligence and advanced analytics, manufacturers can improve throughput by identifying process bottlenecks and providing insights on altering the manufacturing process for better yields (e.g., faster reaction times or greater purity). This can help to reduce production times and increase output. In addition, AI can be used for predictive maintenance, which can help to prevent equipment failures and minimize downtime.

Reduced Costs

Artificial intelligence can also help pharmaceutical companies reduce the costs of API manufacturing. With machine learning, it is possible to optimize the process and make better use of resources (optimizing raw materials used or reducing waste and decreasing energy consumption and operating time).

Improved Product Stability

API products must meet specific stability requirements to ensure safety and effectiveness. Using artificial intelligence in production can help to improve product stability by detecting and correcting any errors early on. This can help ensure that the final product’s active pharmaceutical ingredients are not affected by changes in the manufacturing process.

Pharmaceutical manufacturing processes improvement based on Industry Internet of Things solutions (IIoT) and AI algorithms
Pharmaceutical manufacturing processes improvement based on Industry Internet of Things solutions (IIoT) and AI algorithms

API manufacturers are starting to apply artificial intelligence (AI) in their production processes. There are several potential applications of AI in API manufacturing, including:

  • AI in research and development
  • Predictive maintenance
  • Predictive manufacturing
  • Image recognition and analysis on the production line

Each of these applications can improve the efficiency and quality of the API production process. Let’s take a closer look at each one.

Artificial Intelligence in Research and Development

Pharmaceutical companies have been using artificial intelligence to improve their operations when it comes to R&D activities. One good example of applying machine learning is to use it for process development.

Process modeling is a technique that has been used to develop predictive models of different reaction conditions. This approach can help identify better process conditions and reduce the number of experiments needed for development. In addition, AI can also be used for target identification during the early discovery stages.

Machine learning algorithms are effective in identifying active molecules from large data sets. This can help to improve hit rates during drug discovery and reduce the amount of time and resources needed for lead identification.

Overall, it is clear that artificial intelligence can play an essential role in improving pharmaceutical research and development activities. By using machine learning algorithms, companies can achieve better results while reducing costs and time requirements.

Predictive Manufacturing Processes

Predictive manufacturing is a type of AI that uses machine learning algorithms to predict how a production process will behave under different conditions. Using predictive manufacturing, manufacturers can identify potential problems before they occur and take corrective action. This can help to improve efficiency and quality while reducing costs.

Production process based on predictive modeling for feedback control and process monitoring
Production process based on predictive modeling for feedback control and process monitoring

In addition, pharma companies can use predictive manufacturing for process control. In this scenario, the machine learning algorithm is used to predict the state of a drug manufacturing process at any given time. This information can be immediately used to adjust the process directly as needed. By using predictive control, manufacturers can ensure that products are produced within specifications and minimize the risk of failure.

One application of predictive manufacturing is in the area of batch processing of active ingredients. Variations in the process can affect the quality of the final product. In addition, it can be challenging to detect and correct errors when using this approach.

Predictive manufacturing can help to address these problems by providing feedback control and process monitoring. By using predictive models, manufacturers can get real-time information on how the process performs. In this scenario, the machine learning algorithm predicts the output of a given process based on past data. This information can be used to adjust the parameters of the process as needed. This approach can help to optimize throughput and ensure that products meet quality requirements.

Several metrics can be tracked within each reactor during the batch manufacturing process, including pressure, temperature, density, viscosity, and others. Time series data can provide insights that ML can extract to give predictions, enabling early discovery of unanticipated behaviors, finding early warning signs, and creating reliable alarms that warn about possible quality issues for the final product earlier in the process.
Several metrics can be tracked within each reactor during the batch manufacturing process, including pressure, temperature, density, viscosity, and others. Time series data can provide insights that ML can extract to give predictions, enabling early discovery of unanticipated behaviors, finding early warning signs, and creating reliable alarms that warn about possible quality issues for the final product earlier in the process.

API manufacturers need to ensure that their products meet quality requirements and that the yields from continuous manufacturing are kept on the desired level. They need a way to intensify the processes. One way to do this is by constantly monitoring the process and identifying how changing environment parameters will affect the final product. Similarly, artificial intelligence solutions can make predictions applicable in continuous manufacturing to monitor active pharmaceutical ingredients (APIs) during production.

However, for this approach to be practical, manufacturers need access to real-time data. It is too costly, though, to run processes with altered parameters and without a promise of getting quality products at the end. This is where machine learning can be used to make predictions about the process. By using AI models, manufacturers can get a better understanding of how the process is performing and identify any changes that need to be addressed - in silico first and only when the AI model has high certainty run the actual manufacturing process.

Smart manufacturing with predictive modeling enables production optimization through better throughput, quality, safety, and yield improvements. It is important to note that not only the predictive model is essential here, but the end-to-end custom implementation of a solution that interprets data provides visualization and custom automated actions to streamline pharmaceutical manufacturing.
Smart manufacturing with predictive modeling enables production optimization through better throughput, quality, safety, and yield improvements. It is important to note that not only the predictive model is essential here, but the end-to-end custom implementation of a solution that interprets data provides visualization and custom automated actions to streamline pharmaceutical manufacturing.

Waste Reduction - Minimize Batch Losses

One of the biggest challenges faced by API manufacturers is minimizing batch losses; it can be incredibly costly in biopharmaceutical production. These can be caused by several factors, including errors in the complexity of the manufacturing process, contamination, and product degradation. The manufacturing of APIs is a complex process, and even a tiny process variation can result in the loss of an entire batch. To prevent this, pharmaceutical companies need to continuously monitor their production processes to ensure that they are running smoothly.

Manufacturers have traditionally used a variety of approaches to try to minimize batch losses. These include Statistical Process Control (SPC), which uses historical data, and Multivariate Data Analysis (MVDA) to identify trends in the manufacturing process. This information can then be used to decide how to adjust the process parameters.

However, SPC and multivariate analytics have limitations in identifying small changes in pharmaceuticals production that can lead to significant variations in product quality. In addition, it can be challenging to detect and correct errors when using this approach.

To address these limitations, manufacturers from the pharmaceutical industry are increasingly turning to artificial intelligence solutions. These can be used to create models to identify the relationships between process parameters and product quality. This information can then be used to decide how to adjust the process parameters.

AI models can learn from data and detect patterns that are not detectable by humans. In addition, they can adapt as the manufacturing process changes, allowing them to maintain a high degree of accuracy in predicting product quality. AI software applied for waste reduction also plays a critical role in the environmental impact of drug production.

Related case study: APIs Production Process Predictive Monitoring To improve the current repeatable batch production processes, a producer of active pharmaceutical ingredients approached us to implement AI models and utilize predictive modeling. Our challenge? Building a model that analyzes real-time data streams from the production process and identifies potential outliers that may lead to deterioration of quality, based on historical data. The benefits are improved effectiveness, predictability, and efficiency of manufacturing operations and yields. Read more about this case study.

Quality Assurance

To improve quality assurance, some manufacturers are turning to machine learning solutions. These can be used to develop models that automatically predict potential problems resulting in product alterations. In addition, they can be used to identify the root cause of defects to be corrected.

Traditional fixed process approach with post-process testing of quality results in variability in product quality and yield
Traditional fixed process approach with post-process testing of quality results in variability in product quality and yield

In traditional approaches to manufacturing, a fixed process relies on post-process testing of quality to ensure the product is within specification. Unfortunately, for complex procedures, a fixed process does not guarantee a desired quality and quantity.

Active Pharmaceutical Ingredients manufacturing follows a prescribed set of recipes. The recipe is determined by the active pharmaceutical ingredient and the ingredients and process parameters used to produce it. To ensure that the quality of the API meets specifications, manufacturers use a variety of quality control tests at different points in the production process.

However, these tests can be time-consuming and expensive, and they do not always identify all defects in the product. In addition, even if a fault is identified, it can be challenging to determine what caused it and how to correct it.

Prescriptive feedback control pharmaceutical manufacturing processes
Prescriptive feedback control pharmaceutical manufacturing processes

Machine learning solutions can be used to develop models that can automatically predict product defects. In addition, they can be used to identify the root cause of the problem. Machine learning solutions are a great way to develop models that can automatically predict product anomalies and help with root cause analysis with prescriptive feedback control. This will help speed up the process of finding and fixing these errors, ultimately leading to a more resilient API production process that ensures consistency in product quality and quantity.

Streamlining Production Schedule

Predictive manufacturing can also optimize and streamline production schedules. AI models can help identify the products that are most likely to experience a delay in production so that the necessary steps can be taken to ensure that they are produced on time and meet demand. This helps reduce the risk of delays in product delivery, which can impact customer satisfaction and business operations.

Predictive Maintenance

Another application of AI in pharmaceutical manufacturing is predictive maintenance. In this scenario, machine learning algorithms predict when a piece of equipment will fail. By using predictive maintenance, companies can schedule repairs before equipment fails, thus improving efficiency minimizing downtime and repair costs. In addition, it can also help to extend the life of machines and equipment.

It is difficult to detect small changes in equipment performance in many cases until it becomes a problem. Predictive maintenance uses machine learning algorithms to analyze data from sensors on machines. This data can be used to build models of how the equipment will perform under different conditions. The Industry Internet of Things (IIoT) is another way to apply artificial intelligence in maintenance activities. The IIoT is a network of connected devices that can be used to collect and transmit data. This data can then be used to improve operations and make decisions about optimizing the process and reducing the lifecycle maintenance costs.

maintenence wearout and failure probability vs lifecycle maintenance costs

Manufacturers need access to historical data on equipment failures for predictive maintenance to be effective. The production line that has been in operation for several years assures that the company has significant historical information on failures, repairs, and scheduled maintenance actions. The machine learning algorithm can use this data to build a model of how equipment behaves over time. The data will also be used to improve the accuracy of the predictions made by the machine learning algorithm.

Sensor and Visual Inspection for Quality Assurance

Another application of AI in API manufacturing is image recognition and analysis on the production line. This approach can be used to identify defects in products or contamination in the process environment. In addition, it can also be used for quality control purposes.

In this scenario, images of products are taken as they are produced and analyzed using machine learning algorithms. This data is then used to build models that can detect defects in the product.

AI-based computer-vision quality control. Computer vision can be used to inspect products on the manufacturing floor for various purposes, such as detecting defects, measuring product color, spectra, dimensions, or any other visual parameters, and verifying correct labeling. In this scenario, a camera is mounted above the production line, and images of the products are taken as they pass by. These images are then analyzed using machine learning algorithms to detect defects or abnormalities.
AI-based computer-vision quality control. Computer vision can be used to inspect products on the manufacturing floor for various purposes, such as detecting defects, measuring product color, spectra, dimensions, or any other visual parameters, and verifying correct labeling. In this scenario, a camera is mounted above the production line, and images of the products are taken as they pass by. These images are then analyzed using machine learning algorithms to detect defects or abnormalities.

The use of AI-based image recognition and analysis can help identify defects that may not be detectable by traditional quality control tests. In addition, it can also help speed up the process of identifying and correcting these defects. Using AI-based image recognition and analysis, companies can ensure that their products meet the highest quality standards.

Benefits of Introducing AI to APIs Manufacturing

There are many benefits of introducing AI to APIs production. Some of these benefits include:

  • Faster process development for new drugs
  • Increased resilience to disruptions in production
  • Improved production process
  • Opportunity to increase production yields
  • Reduced risk of product defects and contamination
  • Improved quality control
  • Faster identification and correction of defects
  • Streamlined production schedule
  • Reduced production losses and wasted raw material
  • Reduced downtime and maintenance costs

These benefits contribute to a more resilient pharmaceutical production process that is less likely to experience disruptions or problems. In addition, it also helps improve business efficiency by reducing the amount of time and resources needed for quality assurance activities. This, in turn, results in higher quality products that meet the highest standards.

Resilient Future for Pharmaceutical Manufacturers with Innovative Technologies

The use of AI in API production can help improve efficiency, reduce errors and improve quality. By using predictive maintenance, image recognition and analysis, and other AI-based methods, companies can make their API production process more resilient to disruptions and problems. This, in turn, results in higher quality products that meet the highest standards. AI-powered active ingredient production can help improve efficiency, reduce errors and improve quality.

As the industry continues to evolve, manufacturers need to adopt new technologies that will help them stay competitive. The use of AI software in API production is one such technology that can help manufacturers stay ahead of the curve. With its ability to improve efficiency, reduce risk and improve quality, AI adoption offers several advantages that can benefit pharmaceutical companies across all stages of pharmaceutical development, starting with drug discovery, clinical trials, process development, and finally, manufacturing operations. In addition to these benefits, AI can also help pharmaceutical manufacturers prepare for the future. Read more articles about AI in chemicals here.

Like companies from other industries, pharma enterprises need to rethink their manufacturing approach and supply chain management. Drug manufacturers should look into their operations as their current offshore production, and just-in-time system are now being reevaluated. These strategies have recently proved not to be fully resilient.

Active Pharmaceutical Ingredient production is a complex process that requires a high degree of precision and reliability. Nexocode’s AI experts can help companies from the pharma industry to implement solutions that will improve the resilience of their API production process. Our solutions can help reduce the risk of product defects and contamination, improve quality control, and speed up identifying and correcting defects. In addition, our AI experts can help pharmaceutical companies prepare for the future by implementing new technologies that will help them stay competitive. Contact us today to learn more about our AI-based solutions for drug production.

About the author

Dorota Owczarek

Dorota Owczarek

AI Product Lead & Design Thinking Facilitator

Linkedin profile Twitter

With over ten years of professional experience in designing and developing software, Dorota is quick to recognize the best ways to serve users and stakeholders by shaping strategies and ensuring their execution by working closely with engineering and design teams.
She acts as a Product Leader, covering the ongoing AI agile development processes and operationalizing AI throughout the business.

Would you like to discuss AI opportunities in your business?

Let us know and Dorota will arrange a call with our experts.

Dorota Owczarek
Dorota Owczarek
AI Product Lead

Thanks for the message!

We'll do our best to get back to you
as soon as possible.

This article is a part of

AI in Pharma
14 articles

AI in Pharma

The pharmaceutical industry is one of the most regulated industries in the world. It's also one of the most expensive and challenging industries to work in. Pharma companies, like all other businesses, are looking for ways to reduce costs while improving quality and efficiency. This is where artificial intelligence comes into play!

Follow our article series to find out what are the benefits of AI in pharma and why this tech could be considered a game changer for the pharmaceutical sector.

check it out

Pharma & Life Sciences

Insights on practical AI applications just one click away

Sign up for our newsletter and don't miss out on the latest insights, trends and innovations from this sector.

Done!

Thanks for joining the newsletter

Check your inbox for the confirmation email & enjoy the read!

This site uses cookies for analytical purposes.

Accept Privacy Policy

In the interests of your safety and to implement the principle of lawful, reliable and transparent processing of your personal data when using our services, we developed this document called the Privacy Policy. This document regulates the processing and protection of Users’ personal data in connection with their use of the Website and has been prepared by Nexocode.

To ensure the protection of Users' personal data, Nexocode applies appropriate organizational and technical solutions to prevent privacy breaches. Nexocode implements measures to ensure security at the level which ensures compliance with applicable Polish and European laws such as:

  1. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation) (published in the Official Journal of the European Union L 119, p 1); Act of 10 May 2018 on personal data protection (published in the Journal of Laws of 2018, item 1000);
  2. Act of 18 July 2002 on providing services by electronic means;
  3. Telecommunications Law of 16 July 2004.

The Website is secured by the SSL protocol, which provides secure data transmission on the Internet.

1. Definitions

  1. User – a person that uses the Website, i.e. a natural person with full legal capacity, a legal person, or an organizational unit which is not a legal person to which specific provisions grant legal capacity.
  2. Nexocode – NEXOCODE sp. z o.o. with its registered office in Kraków, ul. Wadowicka 7, 30-347 Kraków, entered into the Register of Entrepreneurs of the National Court Register kept by the District Court for Kraków-Śródmieście in Kraków, 11th Commercial Department of the National Court Register, under the KRS number: 0000686992, NIP: 6762533324.
  3. Website – website run by Nexocode, at the URL: nexocode.com whose content is available to authorized persons.
  4. Cookies – small files saved by the server on the User's computer, which the server can read when when the website is accessed from the computer.
  5. SSL protocol – a special standard for transmitting data on the Internet which unlike ordinary methods of data transmission encrypts data transmission.
  6. System log – the information that the User's computer transmits to the server which may contain various data (e.g. the user’s IP number), allowing to determine the approximate location where the connection came from.
  7. IP address – individual number which is usually assigned to every computer connected to the Internet. The IP number can be permanently associated with the computer (static) or assigned to a given connection (dynamic).
  8. GDPR – Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of individuals regarding the processing of personal data and onthe free transmission of such data, repealing Directive 95/46 / EC (General Data Protection Regulation).
  9. Personal data – information about an identified or identifiable natural person ("data subject"). An identifiable natural person is a person who can be directly or indirectly identified, in particular on the basis of identifiers such as name, identification number, location data, online identifiers or one or more specific factors determining the physical, physiological, genetic, mental, economic, cultural or social identity of a natural person.
  10. Processing – any operations performed on personal data, such as collecting, recording, storing, developing, modifying, sharing, and deleting, especially when performed in IT systems.

2. Cookies

The Website is secured by the SSL protocol, which provides secure data transmission on the Internet. The Website, in accordance with art. 173 of the Telecommunications Act of 16 July 2004 of the Republic of Poland, uses Cookies, i.e. data, in particular text files, stored on the User's end device.
Cookies are used to:

  1. improve user experience and facilitate navigation on the site;
  2. help to identify returning Users who access the website using the device on which Cookies were saved;
  3. creating statistics which help to understand how the Users use websites, which allows to improve their structure and content;
  4. adjusting the content of the Website pages to specific User’s preferences and optimizing the websites website experience to the each User's individual needs.

Cookies usually contain the name of the website from which they originate, their storage time on the end device and a unique number. On our Website, we use the following types of Cookies:

  • "Session" – cookie files stored on the User's end device until the Uses logs out, leaves the website or turns off the web browser;
  • "Persistent" – cookie files stored on the User's end device for the time specified in the Cookie file parameters or until they are deleted by the User;
  • "Performance" – cookies used specifically for gathering data on how visitors use a website to measure the performance of a website;
  • "Strictly necessary" – essential for browsing the website and using its features, such as accessing secure areas of the site;
  • "Functional" – cookies enabling remembering the settings selected by the User and personalizing the User interface;
  • "First-party" – cookies stored by the Website;
  • "Third-party" – cookies derived from a website other than the Website;
  • "Facebook cookies" – You should read Facebook cookies policy: www.facebook.com
  • "Other Google cookies" – Refer to Google cookie policy: google.com

3. How System Logs work on the Website

User's activity on the Website, including the User’s Personal Data, is recorded in System Logs. The information collected in the Logs is processed primarily for purposes related to the provision of services, i.e. for the purposes of:

  • analytics – to improve the quality of services provided by us as part of the Website and adapt its functionalities to the needs of the Users. The legal basis for processing in this case is the legitimate interest of Nexocode consisting in analyzing Users' activities and their preferences;
  • fraud detection, identification and countering threats to stability and correct operation of the Website.

4. Cookie mechanism on the Website

Our site uses basic cookies that facilitate the use of its resources. Cookies contain useful information and are stored on the User's computer – our server can read them when connecting to this computer again. Most web browsers allow cookies to be stored on the User's end device by default. Each User can change their Cookie settings in the web browser settings menu: Google ChromeOpen the menu (click the three-dot icon in the upper right corner), Settings > Advanced. In the "Privacy and security" section, click the Content Settings button. In the "Cookies and site date" section you can change the following Cookie settings:

  • Deleting cookies,
  • Blocking cookies by default,
  • Default permission for cookies,
  • Saving Cookies and website data by default and clearing them when the browser is closed,
  • Specifying exceptions for Cookies for specific websites or domains

Internet Explorer 6.0 and 7.0
From the browser menu (upper right corner): Tools > Internet Options > Privacy, click the Sites button. Use the slider to set the desired level, confirm the change with the OK button.

Mozilla Firefox
browser menu: Tools > Options > Privacy and security. Activate the “Custom” field. From there, you can check a relevant field to decide whether or not to accept cookies.

Opera
Open the browser’s settings menu: Go to the Advanced section > Site Settings > Cookies and site data. From there, adjust the setting: Allow sites to save and read cookie data

Safari
In the Safari drop-down menu, select Preferences and click the Security icon.From there, select the desired security level in the "Accept cookies" area.

Disabling Cookies in your browser does not deprive you of access to the resources of the Website. Web browsers, by default, allow storing Cookies on the User's end device. Website Users can freely adjust cookie settings. The web browser allows you to delete cookies. It is also possible to automatically block cookies. Detailed information on this subject is provided in the help or documentation of the specific web browser used by the User. The User can decide not to receive Cookies by changing browser settings. However, disabling Cookies necessary for authentication, security or remembering User preferences may impact user experience, or even make the Website unusable.

5. Additional information

External links may be placed on the Website enabling Users to directly reach other website. Also, while using the Website, cookies may also be placed on the User’s device from other entities, in particular from third parties such as Google, in order to enable the use the functionalities of the Website integrated with these third parties. Each of such providers sets out the rules for the use of cookies in their privacy policy, so for security reasons we recommend that you read the privacy policy document before using these pages. We reserve the right to change this privacy policy at any time by publishing an updated version on our Website. After making the change, the privacy policy will be published on the page with a new date. For more information on the conditions of providing services, in particular the rules of using the Website, contracting, as well as the conditions of accessing content and using the Website, please refer to the the Website’s Terms and Conditions.

Nexocode Team